CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts

Area of Science:

• Cell Biology
• Hematology
• Stem Cell Research

Background:

• CD14(+) monocytes can differentiate into osteoclasts (OCs).
• A human cell line with stem cell characteristics capable of OC differentiation is needed to study OC development.
• The MUTZ-3 cell line contains both CD34(+) stem cells and CD14(+) cells.

Purpose of the Study:

• To investigate the capacity of MUTZ-3 CD34(+) stem/progenitor cells to differentiate into functional osteoclasts.
• To establish a human cell line model for studying osteoclast commitment, differentiation, and function.

Main Methods:

• Sorted MUTZ-3 CD34(+) and CD14(+) cells were cultured with M-CSF, RANK-L, and TNF-alpha.
• Osteoclast differentiation was assessed by TRAP staining, RT-PCR (for c-fms, RANK, MMP-9, CATK, TRAP, CTR), and resorption pit formation.
• Cell surface marker expression (CD34, CD14, M-CSF-R, RANK, CTR) was analyzed by FACS.

Main Results:

• MUTZ-3 CD34(+) cells successfully differentiated into OCs, expressing key markers like MMP-9, CATK, TRAP, and RANK by day 3, and CTR by day 12.
• Generated OCs formed resorption lacunae on mineralized surfaces and bone slices, indicating functional osteoclast activity.
• A CD14(+)CD34(+)M-CSF-R(+)RANK(+) population was identified in both sorted cell types, suggesting an intermediate differentiation stage.

Conclusions:

• MUTZ-3 cells serve as an effective model for studying osteoclast differentiation.
• The CD14(+)CD34(+)M-CSF-R(+)RANK(+) population represents a transitional stage between CD34 precursors, monocytes, and osteoclasts.